Immunoprecise Antibodies Ltd (NASDAQ:IPA) To Acquire BioStrand BV – Revolutionizing Biotherapeutics

March 30, 2022

At this point in time, there could be a fair degree of focus on the Immunoprecise Antibodies Ltd (NASDAQ:IPA) (TSX.V:IPA) stock, which came into the news cycle earlier on in the week on Tuesday. At the time the company made a key announcement and it may be a good idea for investors to consider taking a look at it a bit more closely. The company announced that it had signed…


ImmunoPrecise Antibodies Ltd (NASDAQ:IPA): Marshall Wace LLP Raises Stock Position

March 7, 2022

NASDAQ listed innovative biotherapeutic company ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) could be the stock to watch today and especially after a major development that took place towards the end of February. Back on February 27, 2022, it emerged that existing institutional investors in the company Marshall Wace LLP had decided to grow their stake in ImmunoPrecise. Key Details When an existing investor raises his stake considerably then it is an indication…